Array-based comparative genomic hybridization analysis of high-grade neuroendocrine tumors of the lung

被引:28
作者
Peng, WX
Shibata, T
Katoh, H
Kokubu, A
Matsuno, Y
Asamura, H
Tsuchiya, R
Kanai, Y
Hosoda, F
Sakiyama, T
Ohki, M
Imoto, I
Inazawa, J
Hirohashi, S
机构
[1] Natl Canc Ctr, Res Inst, Div Pathol, Chuo Ku, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Res Inst, Ctr Genet Med, Chuo Ku, Tokyo 1040045, Japan
[3] Natl Canc Ctr, Thorac Surg Div, Tokyo 1040045, Japan
[4] Natl Canc Ctr, Clin Lab Div, Tokyo 1040045, Japan
[5] Natl Canc Ctr, Res Inst, Canc Genom Project, Chuo Ku, Tokyo 1040045, Japan
[6] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Bunkyo Ku, Tokyo 1138591, Japan
[7] JST, CREST, Kawaguchi, Saitama 3320012, Japan
来源
CANCER SCIENCE | 2005年 / 96卷 / 10期
关键词
D O I
10.1111/j.1349-7006.2005.00092.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We examined a large number of primary high-grade neuroendocrine tumors of the lung (10 small cell lung carcinomas and 31 large cell neuroendocrine carcinomas) by using array-based comparative genomic hybridization using microarrays spotted with 800 bacterial artificial chromosome clones containing tumor-related genes from throughout the human genome. We identified the genome-wide copy number alteration profiles of these tumors, including recurrent amplifications located at 2q21.2, 3q21-27, 3q26, 3q27-29, 5p14.2, 5p13, 7q21.1, 8q21, and 8q24 and homozygous deletions at 1p36, 4p16, 4p16.3, 9p21.3, 9p21, 19p13.3, and 20q13. Our results revealed that small cell lung carcinomas and large cell neuroendocrine carcinomas have multiple characteristic chromosomal alterations in common, but that distinctive alterations also exist between the two subtypes. Moreover, we found that the two subtypes undergo different processes of accumulating these genetic alterations during tumor development. By comparing the genetic profiles with the clinicopathological features, we discovered many chromosomal loci whose alterations were significantly associated with clinical stage and patient prognosis. These results will be valuable for evaluating clinical status, including patient prognosis, and for identifying novel molecular targets for effective therapies.
引用
收藏
页码:661 / 667
页数:7
相关论文
共 21 条
[1]  
[Anonymous], 1999, HIST TYP LUNG PLEUR
[2]   Chromosomal imbalances in human lung cancer [J].
Balsara, BR ;
Testa, JR .
ONCOGENE, 2002, 21 (45) :6877-6883
[3]   Mitoxantrone resistance in a small cell lung cancer cell line is associated with ABCA2 upregulation [J].
Boonstra, R ;
Timmer-Bosscha, H ;
van Echten-Arends, J ;
van der Kolk, DM ;
van den Berg, A ;
de Jong, B ;
Tew, KD ;
Poppema, S ;
de Vries, EGE .
BRITISH JOURNAL OF CANCER, 2004, 90 (12) :2411-2417
[4]   Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas [J].
Douglas, EJ ;
Fiegler, H ;
Rowan, A ;
Halford, S ;
Bicknell, DC ;
Bodmer, W ;
Tomlinson, IPM ;
Carter, NP .
CANCER RESEARCH, 2004, 64 (14) :4817-4825
[5]   Laser capture microdissection [J].
EmmertBuck, MR ;
Bonner, RF ;
Smith, PD ;
Chuaqui, RF ;
Zhuang, ZP ;
Goldstein, SR ;
Weiss, RA ;
Liotta, LA .
SCIENCE, 1996, 274 (5289) :998-1001
[6]   Clinical relevance of chromosome abnormalities in non-small cell lung cancer [J].
Feder, M ;
Siegfried, JM ;
Balshem, A ;
Litwin, S ;
Keller, SM ;
Liu, ZM ;
Testa, JR .
CANCER GENETICS AND CYTOGENETICS, 1998, 102 (01) :25-31
[7]  
Iyoda A, 2001, CANCER-AM CANCER SOC, V91, P1992, DOI 10.1002/1097-0142(20010601)91:11<1992::AID-CNCR1224>3.0.CO
[8]  
2-5
[9]  
LEVIN NA, 1994, CANCER RES, V54, P5086
[10]  
Petersen I, 1997, CANCER RES, V57, P2331